Concepedia

Christina Hanzis

CH

Statistics

Publications

10

Citations

391

H-Index

10

Active since

2009

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

BioBridges (United States)

Christina Hanzis is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and immunotherapy.

Publications per year

2009–2012

10

Publications

10

Bendamustine Therapy in Patients With Relapsed or Refractory Waldenström's Macroglobulinemia

Steven P. Treon, Christina Hanzis, Christina Tripsas et al. · Clinical Lymphoma Myeloma & Leukemia · 2011 · 104 citations

, , +4

Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab‐containing regimen

Steven P. Treon, Christina Hanzis, Robert Manning et al. · British Journal of Haematology · 2011 · 101 citations · Full text

, , +13

Associated Malignancies in Patients with Waldenström's Macroglobulinemia and Their Kin

Christina Hanzis, Rohit P. Ojha, Zachary R. Hunter et al. · Clinical Lymphoma Myeloma & Leukemia · 2011 · 44 citations

, , +5

Hepcidin Is Produced by Lymphoplasmacytic Cells and Is Associated With Anemia in Waldenström's Macroglobulinemia

Bryan Ciccarelli, Christopher J. Patterson, Zachary R. Hunter et al. · Clinical Lymphoma Myeloma & Leukemia · 2011 · 36 citations

, , +6

Familial Disease Predisposition Impacts Treatment Outcome in Patients With Waldenström Macroglobulinemia

Steven P. Treon, Christina Tripsas, Christina Hanzis et al. · Clinical Lymphoma Myeloma & Leukemia · 2012 · 27 citations

, , +5

1–5 of 10